26 Clinical evidence and Science Authors Year Follow-up time (year) Total Implants CAMLOG® Implants Survival in % Comments Retrospective studies Knöfler et al. 2017 20 10165 1,4 6063 SL 3.15 loss rate* Knöfler et al. 2019 20 10165 1,4 6063 SL 1.56 loss rate* Camlog® over 10 years period (2001–2011) Lee et al. 2019 12 19006 1,3,4 1317 SL 99.2 at 5-year 97.7 at 10-year Survival related to implant fracture Seemann et al. 2017 7 69377 1 69377: 11220 RL, 58157 SL 2.78 return rate Return rate of total sold implants (complaint statistics) Semper et al. 2008 6 464 1 464: 411 RL, 53 SL 99.6 Nelson et al. 2008 5 532 1,2 463: 410 RL, 53 SL 99.4 Semper et al. 2007 5 448 1,2 403: 363 RL, 40 SL 99.8 Prospective clinical studies (cohort studies) Vanlioglu et al. 2014 10 253 1 253 SL 100 Strietzel et al. 2007 5 333 1 333 SL 98.5 Beschnidt et al. 2018 5 271 1 271 SL 98.6 Krennmair S et al. 2018 5 284 1 284 SL and RL 99.3 Krennmair S et al. 2019 5 295 1 295 SL 99.3 De Lange et al. 2010 5 774 1 774 SL 96.7 Randomized clinical trials Waller et al. (5) 2020 7.5 28 1 28 SL 100 Messias et al. 2019 5 146 1 146 SL 96.6 RL = Root-Line; SL = Screw-Line *Total implants observed vs lost implants (1) CAMLOG®, (2) Straumann, (3) Biohorizons, (4) Others Tab. 3_Publications reporting mid-term and long-term survival rates of the CAMLOG® Implant System. CLINICAL EVIDENCE FOR CAMLOG® AND CONELOG® IMPLANTS
RkJQdWJsaXNoZXIy MTE0MzMw